Homebiotech

biotech

biotech

Gilead to acquire Tubulis

Jim Cornall - April 14, 2026

biotech

Fast Track Designation for T-cell therapy enhanced with membrane-tethered IL-12 booster

Jim Cornall - April 13, 2026

biotech

Walks to support Lennox-Gastaut syndrome research

Jim Cornall - April 13, 2026

biotech

Precision nanomedicine to target most challenging tumours

Jim Cornall - April 13, 2026

biotech

New biomarker helps assess aggression of glioblastoma

Jim Cornall - April 7, 2026

biotech

Protein helps cancer cells survive treatment

Jim Cornall - April 7, 2026

biotech

Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes

Jim Cornall - April 3, 2026

biotech

IND approval for bispecific ADC

Jim Cornall - April 2, 2026

biotech

World’s largest clinically linked spatial biology atlas launched

Jim Cornall - April 2, 2026

AI

Changing the search for rare disease diagnoses with AI breakthrough

Jim Cornall - April 2, 2026

biotech

Precision medicine helps more patients receive genetic diagnosis

Jim Cornall - April 1, 2026

biotech

Tumour DNA in blood after pre-surgery treatments predicts if breast cancer will return

Jim Cornall - April 1, 2026

123...69 Page 2 of 69

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Gilead to acquire Tubulis

Jim Cornall - April 14, 2026 0

Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis GmbH, a private clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), building...

Fast Track Designation for T-cell therapy enhanced with membrane-tethered IL-12 booster

biotech Jim Cornall - April 13, 2026 0

Walks to support Lennox-Gastaut syndrome research

biotech Jim Cornall - April 13, 2026 0

Precision nanomedicine to target most challenging tumours

biotech Jim Cornall - April 13, 2026 0

Base to Base biotech podcast 54: Parkinson’s disease and peptides

biotech Jim Cornall - April 10, 2026 0